S-HIV-1 OLIGOPEPTIDE-1
Conditioning Agent
Caution
About S-HIV-1 OLIGOPEPTIDE-1
A synthetic peptide modelled on the HIV-1 TAT protein, raising significant regulatory concern due to its pathogenic viral origin sequence.
Detailed Analysis
A 38-amino-acid synthetic protein fragment based on the HIV-1 TAT (Transactivator of Transcription) protein sequence. While chemically synthesised and not infectious, the use of a pathogenic viral protein template is flagged by EU cosmetic safety reviewers. The EU SCCS has expressed concern about peptides derived from viral or bacterial toxins in cosmetic formulations. Restricted to very low use levels; not approved in some markets. Score reflects regulatory uncertainty and public health sensitivity.
What It Does
Skin Benefits
- ✓ Skin conditioning function reported
Known Concerns
- ⚠ Derived from pathogenic viral protein sequence — regulatory sensitivity
- ⚠ EU SCCS concern regarding viral-derived peptide safety evidence
- ⚠ Limited long-term human safety data
Safety Score
Caution
Based on EU regulatory data, published safety research, and ingredient function analysis.
References
EU CosIng Database
European Commission cosmetic ingredient registry
Check your products for S-HIV-1 OLIGOPEPTIDE-1
Scan any cosmetic product to see if it contains this ingredient and get a full safety breakdown.
Download LuxSenseThis information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for skin concerns or allergies.